Oct 28, 2020 | Gut Health

Julia Malkowski, ND, DC, BSc
David Quig, PhD

This webinar will provide an overview of the industry standard GI360 stool test. A primary focus will be the rationale for the essential incorporation of complementary methodologies to evaluate gastrointestinal microbes. Other components covered will be the advantages and limitations of PCR-based testing, culture-based/proteomic testing, and susceptibility testing. Additionally, the highly focused microbiome and dysbiosis evaluation will be highlighted regarding published validation and clinical application. Furthermore, the comprehensive array of stool chemistries will be featured in context with the overall evaluation. Case studies will also be presented to illustrate the clinical value of the GI360. A live Q&A with Dr. Malkowski and Dr. Quig from Doctor’s Data, moderated by the Director of Clinical Support and Education with Evexia Diagnostics, Dr. Sodano, will follow the main presentation.

Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (888) 852-2723.
Contact Us